Form 4: Progyny Executive Chairman David Schlanger Executes Stock Option and Sells Shares
SEC Form 4 Filing
David Schlanger, Executive Chairman of Progyny, Inc., exercised stock options and sold shares of common stock on March 25 and 26, 2024, according to a Form 4 filing with the SEC.
Summary
- On March 25 and 26, 2024, David Schlanger, the Executive Chairman of Progyny, Inc., engaged in transactions involving the company's stock.
- He exercised stock options to acquire 2,597 shares on March 25 and 305 shares on March 26, both at an exercise price of $3.9545 per share.
- Concurrently, Schlanger sold 2,597 shares on March 25 at a weighted average price of $37.6504 and 305 shares on March 26 at a weighted average price of $37.5034.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan established on June 23, 2023.
- Following these transactions, Schlanger directly owns 86,312 shares of common stock and holds options for 1,381,294 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's future prospects.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to investors regarding the actions of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider sentiment.
Key Dates
| Date | Description |
|---|---|
| 2023-06-23 | Date of entry into Rule 10b5-1 trading plan |
| 2024-03-25 | Date of stock option exercise and share sale |
| 2024-03-26 | Date of stock option exercise and share sale |
| 2024-03-27 | Date of signature on the Form 4 filing |
| 2029-05-23 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.